Hereditary Testing Market By Test Type (Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, Diagnostic Testing, Preimplantation Genetic Diagnosis (PGD), Others), By Disease Type (Hereditary Cancer, Cardiovascular Disorders, Neurological Disorders, Hematological Disorders, Endocrine & Metabolic Disorders, Others), By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Sanger Sequencing, Microarrays, Comparative Genomic Hybridization (CGH), Others), By Sample Type (Blood, Saliva, Buccal Swab, Amniotic Fluid, Chorionic Villus, Others), By End-user (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutions, Specialty Genetic Centers, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles and Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Test Types

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Hereditary Testing Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors.

3.2.1. The raising prevalence of genetic disorders is increasing the demand for early detection through hereditary testing.

3.2.2. Advancements in genomic technologies are making hereditary testing faster, more accurate, and cost-effective.

3.2.3. Growing awareness and acceptance of personalized medicine is encouraging more people to undergo genetic testing.

3.3. Key industry pitfalls & challenges

3.3.1. The high cost of genetic tests can limit accessibility, especially in low- and middle-income countries.

3.3.2. Privacy and ethical concerns around genetic data storage and usage may deter adoption.

3.3.3. Limited genetic counselling services can affect proper interpretation and decision-making based on test results.

3.4. Market Opportunities

3.4.1. Expansion of direct-to-consumer (DTC) genetic testing kits opens up new customer segments globally.

3.4.2. Integration of AI in genetic data analysis is improving prediction accuracy and scalability.

3.4.3. Rising investments in healthcare and genomics in emerging markets provide significant growth potential.

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Hereditary Testing Market Test Type Segment Analysis

4.1. Overview

4.1.1. Market Revenue Share, By Test Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Predictive Testing

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Carrier Testing

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Prenatal Testing

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.5. Newborn Screening

4.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.6. Diagnostic Testing

4.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.7. Preimplantation Genetic Diagnosis (PGD)

4.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.8. Others

4.8.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Hereditary Testing Market, Disease Type Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Disease Type, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Hereditary Cancer

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Cardiovascular Disorders

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Neurological Disorders

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Hematological Disorders

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.6. Endocrine & Metabolic Disorders

5.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.7. Others

5.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Hereditary Testing Market, Technology Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Technology, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Polymerase Chain Reaction (PCR)

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Next-Generation Sequencing (NGS)

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Sanger Sequencing

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.5. Microarrays

6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.6. Comparative Genomic Hybridization (CGH)

6.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.7. Others

6.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Hereditary Testing Market, Sample Type Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Sample Type, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Blood

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Saliva

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Buccal Swab

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.5. Amniotic Fluid

7.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.6. Chorionic Villus

7.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.7. Others

7.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Hereditary Testing Market, End-user Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By End-user, 2025 & 2035

8.1.2. Key Market Trends, Growth Factors, & Opportunities

8.2. Hospitals & Clinics

8.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.3. Diagnostic Laboratories

8.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.4. Research & Academic Institutions

8.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.5. Specialty Genetic Centers

8.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.6. Others

8.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

9. Hereditary Testing Market, Region Segment Analysis

9.1. Overview

9.1.1. Global Market Revenue Share, By Region, 2025 & 2035

9.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

9.2. North America

9.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

9.2.2. North America Market Revenue, By Test Type, 2025-2035

9.2.3. North America Market Revenue, By Disease Type, 2025-2035

9.2.4. North America Market Revenue, By Technology, 2025-2035

9.2.5. North America Market Revenue, By Sample Type, 2025-2035

9.2.6. North America Market Revenue, By End-user, 2025-2035

9.2.7. The U.S.

9.2.7.1. U.S. Market Revenue, By Test Type, 2025-2035

9.2.7.2. U.S. Market Revenue, By Disease Type, 2025-2035

9.2.7.3. U.S. Market Revenue, By Technology, 2025-2035

9.2.7.4. U.S. Market Revenue, By Sample Type, 2025-2035

9.2.7.5. U.S. Market Revenue, By End-user, 2025-2035

9.2.8. Canada

9.2.8.1. Canada Market Revenue, By Test Type, 2025-2035

9.2.8.2. Canada Market Revenue, By Disease Type, 2025-2035

9.2.8.3. Canada Market Revenue, By Technology, 2025-2035

9.2.8.4. Canada Market Revenue, By Sample Type, 2025-2035

9.2.8.5. Canada Market Revenue, By End-user, 2025-2035

9.3. Europe

9.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)

9.3.2. Europe Market Revenue, By Test Type, 2025-2035

9.3.3. Europe Market Revenue, By Disease Type, 2025-2035

9.3.4. Europe Market Revenue, By Technology, 2025-2035

9.3.5. Europe Market Revenue, By Sample Type, 2025-2035

9.3.6. Europe Market Revenue, By End-user, 2025-2035

9.3.7. Germany

9.3.7.1. Germany Market Revenue, By Test Type, 2025-2035

9.3.7.2. Germany Market Revenue, By Disease Type, 2025-2035

9.3.7.3. Germany Market Revenue, By Technology, 2025-2035

9.3.7.4. Germany Market Revenue, By Sample Type, 2025-2035

9.3.7.5. Germany Market Revenue, By End-user, 2025-2035

9.3.8. France

9.3.8.1. France Market Revenue, By Test Type, 2025-2035

9.3.8.2. France Market Revenue, By Disease Type, 2025-2035

9.3.8.3. France Market Revenue, By Technology, 2025-2035

9.3.8.4. France Market Revenue, By Sample Type, 2025-2035

9.3.8.5. France Market Revenue, By End-user, 2025-2035

9.3.9. U.K.

9.3.9.1. U.K. Market Revenue, By Test Type, 2025-2035

9.3.9.2. U.K. Market Revenue, By Disease Type, 2025-2035

9.3.9.3. U.K. Market Revenue, By Technology, 2025-2035

9.3.9.4. U.K. Market Revenue, By Sample Type, 2025-2035

9.3.9.5. U.K. Market Revenue, By End-user, 2025-2035

9.3.10. Italy

9.3.10.1. Italy Market Revenue, By Test Type, 2025-2035

9.3.10.2. Italy Market Revenue, By Disease Type, 2025-2035

9.3.10.3. Italy Market Revenue, By Technology, 2025-2035

9.3.10.4. Italy Market Revenue, By Sample Type, 2025-2035

9.3.10.5. Italy Market Revenue, By End-user, 2025-2035

9.3.11. Spain

9.3.11.1. Spain Market Revenue, By Test Type, 2025-2035

9.3.11.2. Spain Market Revenue, By Disease Type, 2025-2035

9.3.11.3. Spain Market Revenue, By Technology, 2025-2035

9.3.11.4. Spain Market Revenue, By Sample Type, 2025-2035

9.3.11.5. Spain Market Revenue, By End-user, 2025-2035

9.3.12. Rest of Europe

9.3.12.1. Rest of Europe Market Revenue, By Test Type, 2025-2035

9.3.12.2. Rest of Europe Market Revenue, By Disease Type, 2025-2035

9.3.12.3. Rest of Europe Market Revenue, By Technology, 2025-2035

9.3.12.4. Rest of Europe Market Revenue, By Sample Type, 2025-2035

9.3.12.5. Rest of Europe Market Revenue, By End-user, 2025-2035

9.4. Asia Pacific

9.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)

9.4.2. Asia Pacific Market Revenue, By Test Type, 2025-2035

9.4.3. Asia Pacific Market Revenue, By Disease Type, 2025-2035

9.4.4. Asia Pacific Market Revenue, By Technology, 2025-2035

9.4.5. Asia Pacific Market Revenue, By Sample Type, 2025-2035

9.4.6. Asia Pacific Market Revenue, By End-user, 2025-2035

9.4.7. China

9.4.7.1. China Market Revenue, By Test Type, 2025-2035

9.4.7.2. China Market Revenue, By Disease Type, 2025-2035

9.4.7.3. China Market Revenue, By Technology, 2025-2035

9.4.7.4. China Market Revenue, By Sample Type, 2025-2035

9.4.7.5. China Market Revenue, By End-user, 2025-2035

9.4.8. Japan

9.4.8.1. Japan Market Revenue, By Test Type, 2025-2035

9.4.8.2. Japan Market Revenue, By Disease Type, 2025-2035

9.4.8.3. Japan Market Revenue, By Technology, 2025-2035

9.4.8.4. Japan Market Revenue, By Sample Type, 2025-2035

9.4.8.5. Japan Market Revenue, By End-user, 2025-2035

9.4.9. India

9.4.9.1. India Market Revenue, By Test Type, 2025-2035

9.4.9.2. India Market Revenue, By Disease Type, 2025-2035

9.4.9.3. India Market Revenue, By Technology, 2025-2035

9.4.9.4. India Market Revenue, By Sample Type, 2025-2035

9.4.9.5. India Market Revenue, By End-user, 2025-2035

9.4.10. Australia

9.4.10.1. Australia Market Revenue, By Test Type, 2025-2035

9.4.10.2. Australia Market Revenue, By Disease Type, 2025-2035

9.4.10.3. Australia Market Revenue, By Technology, 2025-2035

9.4.10.4. Australia Market Revenue, By Sample Type, 2025-2035

9.4.10.5. Australia Market Revenue, By End-user, 2025-2035

9.4.11. South Korea

9.4.11.1. South Korea Market Revenue, By Test Type, 2025-2035

9.4.11.2. South Korea Market Revenue, By Disease Type, 2025-2035

9.4.11.3. South Korea Market Revenue, By Technology, 2025-2035

9.4.11.4. South Korea Market Revenue, By Sample Type, 2025-2035

9.4.11.5. South Korea Market Revenue, By End-user, 2025-2035

9.4.12. Singapore

9.4.12.1. Singapore Market Revenue, By Test Type, 2025-2035

9.4.12.2. Singapore Market Revenue, By Disease Type, 2025-2035

9.4.12.3. Singapore Market Revenue, By Technology, 2025-2035

9.4.12.4. Singapore Market Revenue, By Sample Type, 2025-2035

9.4.12.5. Singapore Market Revenue, By End-user, 2025-2035

9.4.13. Rest of Asia Pacific

9.4.13.1. Rest of Asia Pacific Market Revenue, By Test Type, 2025-2035

9.4.13.2. Rest of Asia Pacific Market Revenue, By Disease Type, 2025-2035

9.4.13.3. Rest of Asia Pacific Market Revenue, By Technology, 2025-2035

9.4.13.4. Rest of Asia Pacific Market Revenue, By Sample Type, 2025-2035

9.4.13.5. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

9.5. Latin America

9.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)

9.5.2. Latin America Market Revenue, By Test Type, 2025-2035

9.5.3. Latin America Market Revenue, By Disease Type, 2025-2035

9.5.4. Latin America Market Revenue, By Technology, 2025-2035

9.5.5. Latin America Market Revenue, By Sample Type, 2025-2035

9.5.6. Latin America Market Revenue, By End-user, 2025-2035

9.5.7. Brazil

9.5.7.1. Brazil Market Revenue, By Test Type, 2025-2035

9.5.7.2. Brazil Market Revenue, By Disease Type, 2025-2035

9.5.7.3. Brazil Market Revenue, By Technology, 2025-2035

9.5.7.4. Brazil Market Revenue, By Sample Type, 2025-2035

9.5.7.5. Brazil Market Revenue, By End-user, 2025-2035

9.5.8. Argentina

9.5.8.1. Argentina Market Revenue, By Test Type, 2025-2035

9.5.8.2. Argentina Market Revenue, By Disease Type, 2025-2035

9.5.8.3. Argentina Market Revenue, By Technology, 2025-2035

9.5.8.4. Argentina Market Revenue, By Sample Type, 2025-2035

9.5.8.5. Argentina Market Revenue, By End-user, 2025-2035

9.5.9. Mexico

9.5.9.1. Mexico Market Revenue, By Test Type, 2025-2035

9.5.9.2. Mexico Market Revenue, By Disease Type, 2025-2035

9.5.9.3. Mexico Market Revenue, By Technology, 2025-2035

9.5.9.4. Mexico Market Revenue, By Sample Type, 2025-2035

9.5.9.5. Mexico Market Revenue, By End-user, 2025-2035

9.5.10. Rest of Latin America

9.5.10.1. Rest of Latin America Market Revenue, By Test Type, 2025-2035

9.5.10.2. Rest of Latin America Revenue, By Disease Type, 2025-2035

9.5.10.3. Rest of Latin America Market Revenue, By Technology, 2025-2035

9.5.10.4. Rest of Latin America Market Revenue, By Sample Type, 2025-2035

9.5.10.5. Rest of Latin America Market Revenue, By End-user, 2025-2035

9.6. MEA

9.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)

9.6.2. MEA Market Revenue, By Test Type, 2025-2035

9.6.3. MEA Market Revenue, By Disease Type, 2025-2035

9.6.4. MEA Market Revenue, By Technology, 2025-2035

9.6.5. MEA Market Revenue, By Sample Type, 2025-2035

9.6.6. MEA Market Revenue, By End-user, 2025-2035

9.6.7. GCC Countries

9.6.7.1. GCC Countries Market Revenue, By Test Type, 2025-2035

9.6.7.2. GCC Countries Market Revenue, By Disease Type, 2025-2035

9.6.7.3. GCC Countries Market Revenue, By Technology, 2025-2035

9.6.7.4. GCC Countries Market Revenue, By Sample Type, 2025-2035

9.6.7.5. GCC Countries Market Revenue, By End-user, 2025-2035

9.6.8. South Africa

9.6.8.1. South Africa Market Revenue, By Test Type, 2025-2035

9.6.8.2. South Africa Market Revenue, By Disease Type, 2025-2035

9.6.8.3. South Africa Market Revenue, By Technology, 2025-2035

9.6.8.4. South Africa Market Revenue, By Sample Type, 2025-2035

9.6.8.5. South Africa Market Revenue, By End-user, 2025-2035

9.6.9. Rest of Middle-East & Africa

9.6.9.1. Rest of Middle-East & Africa Market Revenue, By Test Type, 2025-2035

9.6.9.2. Rest of Middle-East & Africa Market Revenue, By Disease Type, 2025-2035

9.6.9.3. Rest of Middle-East & Africa Market Revenue, By Technology, 2025-2035

9.6.9.4. Rest of Middle-East & Africa Market Revenue, By Sample Type, 2025-2035

9.6.9.5. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

10. Company Profile

10.1. Myriad Genetics, Inc.

10.1.1. Business Overview

10.1.2. Financial Performance

10.1.3. Product/Service Offerings

10.1.4. Strategies & recent developments

10.1.5. SWOT Analysis

10.2. Invitae Corporation

10.2.1. Business Overview

10.2.2. Financial Performance

10.2.3. Product/Service Offerings

10.2.4. Strategies & recent developments

10.2.5. SWOT Analysis

10.3. 23andMe, Inc.

10.3.1. Business Overview

10.3.2. Financial Performance

10.3.3. Product/Service Offerings

10.3.4. Strategies & recent developments

10.3.5. SWOT Analysis

10.4. Ambry Genetics

10.4.1. Business Overview

10.4.2. Financial Performance

10.4.3. Product/Service Offerings

10.4.4. Strategies & recent developments

10.4.5. SWOT Analysis

10.5. GeneDx

10.5.1. Business Overview

10.5.2. Financial Performance

10.5.3. Product/Service Offerings

10.5.4. Strategies & recent developments

10.5.5. SWOT Analysis

10.6. Color Genomics, Inc.

10.6.1. Business Overview

10.6.2. Financial Performance

10.6.3. Product/Service Offerings

10.6.4. Strategies & recent developments

10.6.5. SWOT Analysis

10.7. Illumina, Inc.

10.7.1. Business Overview

10.7.2. Financial Performance

10.7.3. Product/Service Offerings

10.7.4. Strategies & recent developments

10.7.5. SWOT Analysis

10.8. Fulgent Genetics, Inc.

10.8.1. Business Overview

10.8.2. Financial Performance

10.8.3. Product/Service Offerings

10.8.4. Strategies & recent developments

10.8.5. SWOT Analysis

10.9. Centogene N.V.

10.9.1. Business Overview

10.9.2. Financial Performance

10.9.3. Product/Service Offerings

10.9.4. Strategies & recent developments

10.9.5. SWOT Analysis

10.10. PreventionGenetics, LLC

10.10.1. Business Overview

10.10.2. Financial Performance

10.10.3. Product/Service Offerings

10.10.4. Strategies & recent developments

10.10.5. SWOT Analysis

10.11. PathGroup, Inc.

10.11.1. Business Overview

10.11.2. Financial Performance

10.11.3. Product/Service Offerings

10.11.4. Strategies & recent developments

10.11.5. SWOT Analysis

10.12. Natera, Inc.

10.12.1. Business Overview

10.12.2. Financial Performance

10.12.3. Product/Service Offerings

10.12.4. Strategies & recent developments

10.12.5. SWOT Analysis

10.13. NeoGenomics Laboratories, Inc.

10.13.1. Business Overview

10.13.2. Financial Performance

10.13.3. Product/Service Offerings

10.13.4. Strategies & recent developments

10.13.5. SWOT Analysis

10.14. Helix OpCo, LLC

10.14.1. Business Overview

10.14.2. Financial Performance

10.14.3. Product/Service Offerings

10.14.4. Strategies & recent developments

10.14.5. SWOT Analysis

10.15. Thermo Fisher Scientific Inc.

10.15.1. Business Overview

10.15.2. Financial Performance

10.15.3. Product/Service Offerings

10.15.4. Strategies & recent developments

10.15.5. SWOT Analysis